Order Article Reprints

Curley P, Hobson JJ, Liptrott NJ, Makarov E, Al-khouja A, Tatham L, David CAW, Box H, Neary M, Sharp J, et al. Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations. Pharmaceutics. 2023; 15(7):1835. https://doi.org/10.3390/pharmaceutics15071835

Curley, Paul, James J. Hobson, Neill J. Liptrott, Edward Makarov, Amer Al-khouja, Lee Tatham, Christopher A. W. David, Helen Box, Megan Neary, Joanne Sharp, and et al. 2023. "Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations" Pharmaceutics 15, no. 7: 1835. https://doi.org/10.3390/pharmaceutics15071835

Curley, P., Hobson, J. J., Liptrott, N. J., Makarov, E., Al-khouja, A., Tatham, L., David, C. A. W., Box, H., Neary, M., Sharp, J., Pertinez, H., Meyers, D., Flexner, C., Freel Meyers, C. L., Poluektova, L., Rannard, S., & Owen, A. (2023). Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations. Pharmaceutics, 15(7), 1835. https://doi.org/10.3390/pharmaceutics15071835